🔥MORPHEUS-Phase Ib/II Liver study: Tiragolumab in combination with AtezoBev in #hepatocellularcarcinoma #ASCO23
👉Interesting signal of activity for anti-TIGIT 💊in #HCC (despite control arm 🤨), looking forward to IMbrave152/ SKYSCRAPER-14
ESMO - Eur. Oncology OncoAlert EASL Education EASL Education

#AudioVisualAbstract : Open Versus Laparoscopic #RightHepatectomy for #HepatocellularCarcinoma Following Sequential TACE–PVE : A Multicentric Comparative Study Goumard Claire Hôpital Pitié Salpêtrière - AP-HP Sorbonne Université

rdcu.be/drWfw

HOPE for the Week: The role of cold ischemia time and hypothermic perfusion in predicting early hepatocellular carcinoma recurrences after liver transplantation.

#HOPEForTheWeek #HepatocellularCarcinoma

onlinelibrary.wiley.com/doi/10.1111/ao…

#AudioVisualAbstract : #TransferrinReceptor is Associated with Sensitivity to #FerroptosisInducers in #HepatocellularCarcinoma

rdcu.be/dv2zS

#AudioVisualAbstract : Treatment #Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I–II #HepatocellularCarcinoma Douglas Swords Timothy Newhook Jean-Nicolas Vauthey MD MD Anderson Cancer Center

rdcu.be/dFp69

Lisa Newman, MD MPH

Tremelimumab plus durvalumab (STRIDE) in HCC-HIMALAYA update - Erman Akkus
oncodaily.com/36392.html

#AnkaraUniversity #Cancer #Durvalumab #ESMO #HCC #HepatocellularCarcinoma #OncoDaily #Oncology #Sorafenib

🎙️SBRT showed ⬆️local antitumoral activity for #HCC than TACE-DEB, w/o detrimental effects on OS, tox & QoL‼️ OncoAlert IJROBP - The Red Journal
📌Ph3 RCT: TACE-DEB ✖️ SBRT treatments for #hepatocellularcarcinoma (HCC)
TACE-DEB : Max 4 procedures; ablation allowed after incomplete TACE-DEB

#AdvancedGlycationEndproduct (AGE)⏫liver matrix #Viscoelasticity (Collagen bundle network with shorter fibers & smaller angles), but not #Stiffness
#T2DM #NASH #MASH

A mechanosensitive integrin β1–Tensin 1– #YAP cascade (⏫by high Viscoelasticity) ⏫ #HepatoCellularCarcinoma

Thank you ESMO - Eur. Oncology for the invitation as Faculty in the just concluded ESMO Preceptorship on Liver Cancer – the first ESMO educational course held in Kenya!
It was such a pleasure and a great learning experience! #Quality #standardofcare #livercancer #hepatocellularcarcinoma

Watch Riad Salem, MD, MBA & Mark Yarchoan, MD (@markyarchoan) discuss the latest #Hepatocellularcarcinoma #HCC updates SIO - to participate, visit: bit.ly/HCCVirtual24T x.com/i/broadcasts/1…

Researchers found a correlation between adverse events and clinical outcomes in a study of patients with #hepatocellularCarcinoma who were treated with atezolizumab combined with bevacizumab. Reported in Targeted Oncology. bit.ly/3ULFC70 #HCC

Happy to announce I'll be presenting our work on the changing treatment patterns for #HepatocellularCarcinoma at the upcoming ASCO Medical Student & Resident Abstract Forum. Thank you Dana-Farber Division of Population Sciences and Chris Manz for the support on this important topic. #LiverTwitter #GItwitter

Ablation of left lobe heptocellular carcinoma HCC with good results UT Houston_IR
#InterventionalRadiology #InterventionalOncology #minimallyinvasiveprocedures #IAmIR #HepatocellularCarcinoma #HVC #Cancer #Therapy #Management #GlobalEducation #ablation #LocalRegionalTherapy

#TACE + #Durvalumab + #Bevacizumab demonstrates superior PFS (23% reduced risk) when compared to #TACE alone for the treatment of #hepatocellularcarcinoma .

Congratulations to the #Emerald1 investigators. Welcome the #combinationtherapy era.🧩

astrazeneca.com/media-centre/p…

During #NCRM24 , we thank patients, their families, investigators & their clinical teams for making advances in #cancer research possible. Our diverse pipeline includes #mRNA development candidates for #HepatocellularCarcinoma & #NSCLC . See how to support: brnw.ch/21wJlRY

🟪New Article in press❕

Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multi-center real world study with focus on bleeding and thromboembolic events

🔓 #OpenAccess at 👉jhep-reports.eu/article/S2589-…

#LiverTwitter
#HepatocellularCarcinoma
#HCC

#tb to 2022 ⬅️
Study Protocol: Adjuvant Holmium-166 #Radioembolization After #RadiofrequencyAblation in Early-Stage #HepatocellularCarcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)
link.springer.com/article/10.100…
#OpenAccess 🔓

PUBLISHED: #PerioperativeLymphopenia is Associated with Increased Risk of Recurrence and Worse Survival Following #Hepatectomy for #HepatocellularCarcinoma . rdcu.be/dvHlB Society of Surgical Oncology

🟪NEW Article in press❕

Applications of single-cell multi-omics in liver cancer

🔓 #OpenAccess at 👉jhep-reports.eu/article/S2589-…

#LiverTwitter
#HepatocellularCarcinoma
#HCC